IL17A and tuberculosis: As shown in Fig. 3d, IL-17+ ILC1 (8.79%) was more than IFN-γ+ ILC1 (4.37%) in TB group (P < 0.0001), which implied a bias of ILC1 into IL-17-expressing phenotype in active TB disease.